AVNS
Avanos Medical, Inc. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -7.1% ·
share flow +1.5% ·
net new positions -7.7%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 79 | +1 | 26.26M | $650.94M | +10 | −9 |
| Q1 2026 | 81 | -1 | 26.75M | $374.51M | +2 | −3 |
| Q4 2025 | 82 | 0 | 30.47M | $342.19M | +2 | −2 |
| Q3 2025 | 15 | -1 | 19.76M | $228.46M | n/a | −1 |
| Q2 2025 | 13 | -1 | 16.90M | $206.81M | n/a | −1 |
| Q1 2025 | 11 | -1 | 5.14M | $73.66M | +1 | −2 |
| Q4 2024 | 12 | 0 | 4.33M | $68.85M | +1 | −1 |
| Q3 2024 | 11 | 0 | 2.55M | $61.16M | n/a | n/a |
| Q2 2024 | 11 | n/a | 2.57M | $51.15M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 6.83M | n/a | $83.59M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (passive) | 4.46M | n/a | $54.65M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 1.92M | -0.6% | $23.47M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 1.19M | +9.4% | $14.59M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Geode Capital Management ✦ (passive) | 1.07M | -0.2% | $13.15M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | AQR Capital Management ✦ | 560.05K | +190.4% | $6.86M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 7 | Millennium Management ✦ | 217.34K | -60.3% | $2.66M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 204.54K | n/a | $2.50M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 194.72K | +47.3% | $2.38M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 96.80K | +472.8% | $1.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 68.17K | +207.6% | $834,352 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 48.20K | +1.6% | $590,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 28.70K | -44.0% | $351,325 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $563,758 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 255 holders, 44.71M shares, $512.85M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.